Eva Idén is on the Board of Directors at Infant Bacterial Therapeutics. She has extensive experience in leading management positions in Astra and AstraZeneca. Currently, she is a consultant in leadership and organizational development and is the business owner of Better & Beyond AB and a partner in Inflecto AB. Eva Idén is also on the board of Better & Beyond AB.
Eva earned her degree in Chemical Engineering from the Chalmers University of Technology.
Links